We are studying genetic risk factors and long-term complications of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) (IRB approval#191350). Please share this flyer with SJS/TEN patients before they leave your Burn Unit or when you see them in the clinic for follow-up. THIS STUDY REQUIRES NO IN-PERSON COMMITMENT. We have IRB approval for SJS survivors to contact us through the REDCap link on the flier.
Please contact the study team with any questions:
Elizabeth J. Phillips, MD, FIDSA, FAAAAI Professor & John A. Oates Chair in Clinical Research, Department of Medicine, Director, Center for Drug Safety and Immunology. Vanderbilt University Medical Center (615) 310-0339 or firstname.lastname@example.org